1-800-FLOWERS.COM, Inc. Reports Fiscal 2025 Fourth Quarter and Year-End Results
Reports Fiscal Year 2025 Revenue of $1.69 Billion and a Net Loss of $200.0 Million, which Includes a $143.8 million Non-Cash Goodwill and Intangible Impairment Charge... Read more.
Caleres Reports Second Quarter 2025 Results
ST. LOUIS–(BUSINESS WIRE)–Caleres (NYSE: CAL), a market-leading portfolio of consumer-driven footwear brands, today reported financial results for the... Read more.
Rithm Capital to Acquire Crestline
Strategic Acquisition of $17 Billion Private Credit and Alternative Investment Solutions Manager Significantly Strengthens Rithm’s Asset Management Platform Adds... Read more.
BJ’s Wholesale Club Members Save 25% or More Over Grocery Store Prices
BJ’s offers steep savings for members looking to beat high grocery store prices MARLBOROUGH, Mass.–(BUSINESS WIRE)–As consumers continue to feel challenged... Read more.
Ingevity announces agreement to sell North Charleston crude tall oil refinery and majority of Industrial Specialties product line to Mainstream Pine Products
Divestiture reduces portfolio volatility, strengthens Ingevity’s margin and cash flow profile and enhances future strategic optionality The all-cash transaction... Read more.
1Money Secures 34 U.S. Money Transmitter Licenses and Bermuda BMA Class F License to Support Stablecoin Payments Worldwide
1Money Now Surpasses both Bridge and BVNK in Total U.S. Licenses, Creating a Path to Offer Stablecoin Orchestration Services that Directly Connects to the 1Money... Read more.
Shoe Carnival Reports Second Quarter Fiscal 2025 Results
FORT MILL, S.C.–(BUSINESS WIRE)–Shoe Carnival, Inc. (Nasdaq: SCVL) (the “Company”), a leading retailer of footwear and accessories for the family,... Read more.
U.S. Bank Launches New Embedded Payroll Solution for Small Businesses
All-in-one solution provides a single view across banking, payments and payroll MINNEAPOLIS–(BUSINESS WIRE)–U.S. Bank today announced U.S. Bank Payroll,... Read more.
Vaxiion Therapeutics Announces Completion of Phase 1a Dose Escalation and Initiation of a Phase 1b Dose Expansion Study for Intralesional Administration of VAX014 in Combination with PD-1 Directed Checkpoint Blockade
SAN DIEGO–(BUSINESS WIRE)–Vaxiion Therapeutics today announced completion of the dose escalation segment of its ongoing multicenter Phase 1 study evaluating... Read more.
Netcracker Advances Agentic AI for Telecom With a Focus on Scale, Openness and Measurable Business Impact
Netcracker Provides a Trusted Path for Telecom Service Providers to Take Agentic AI Beyond Pilot Programs and Into Large-Scale, Real-World Deployments WALTHAM, Mass.–(BUSINESS... Read more.